Rationale Drug-associated environmental stimuli may serve as conditioned reinforcers to enhance drug self-administration behaviors in humans and laboratory animals. However, it can be difficult to distinguish experimentally the conditioned reinforcing effects of a stimulus from other behavioral processes that can change rates of responding. Objectives To characterize the conditioned reinforcing effects of a stimulus paired with the μ-opioid agonist, remifentanil, using a new-response acquisition procedure in the rat. Methods First, in Pavlovian conditioning (PAV) sessions, rats received response-independent IV injections of remifentanil and presentations of a light-noise compound stimulus. In paired PAV groups, injections and stimulus presentations always co-occurred. In random PAV control groups, injections and stimulus presentations occurred with no consistent relationship. Second, in instrumental acquisition (ACQ) sessions, all animals could respond in an active nose-poke that produced the stimulus alone or in an inactive nose-poke that had no scheduled consequences. Results During ACQ, rats made significantly more active nose-pokes than inactive nose-pokes after paired PAV, but not after random PAV. Between groups, rats also made more active nose-pokes after paired PAV than after random PAV. After paired PAV, increased active responding was obtained under different schedules of reinforcement, persisted across multiple ACQ sessions, and depended on the number of PAV sessions conducted. Conclusions The remifentanil-paired stimulus served as a conditioned reinforcer for nose-poking: responding depended on both the contingency between the stimulus and remifentanil and the contingency between the nosepoke and the stimulus. Generally, new-response acquisition procedures may provide valid, flexible models for studying opioid-based conditioned reinforcement.
Exposure to drug-associated environmental stimuli can significantly enhance drug self-administration behaviors in both humans and laboratory animals (Everitt and Robbins 2000; Olive and Kalivas 2011; Le Foll and Goldberg 2005; See 2005 ). Many of these effects are consistent with the drug-associated stimuli functioning as conditioned reinforcers to increase the frequency of drug-taking and/or drug-seeking responses; however, it can be difficult experimentally to distinguish conditioned reinforcement from the other associative and nonassociative effects of drug exposure and stimulus presentation (Cunningham 1993; Kelleher and Gollub 1962; Mackintosh 1974; Williams 1994) . Treatments for drug abuse and dependence are increasingly focused on techniques to reduce human drug takers' reactions to drug-associated stimuli (e.g., Milton and Everitt 2010; Myers and Carlezon 2010; Taylor et al. 2009 ). To decrease problematic drug-related responses while minimizing the risk of disruption to other, more adaptive behaviors, these treatments should target precisely the specific learning mechanisms responsible for drug-stimulus associations and stimulus-maintained behaviors (cf., Conklin and Tiffany 2002; Hogarth and Duka 2006) . To help address the specific contributions that conditioned reinforcement can make to drug abuse and dependence (as distinguished, even, from other Pavlovian conditioned effects; Milton and Everitt 2010) , thorough behavioral assessments are needed to characterize the conditioned reinforcing effects of drugassociated stimuli and to determine the necessary and sufficient conditions for such stimuli to act as conditioned reinforcers.
Three criteria must be satisfied to establish that a stimulus is, indeed, acting as a conditioned reinforcer (Mackintosh 1974, p. 234) . Changes in the rate of the response that produces the stimulus must (1) not depend on a current or historical association between the response and a primary reinforcer; rather, rates must depend (2) on the Pavlovian association between a primary reinforcer and the stimulus and (3) on the instrumental association between the response and the stimulus. Among the experimental procedures developed to study conditioned reinforcement (reviewed by Williams 1994) , new-response acquisition is considered particularly rigorous because it can generate behavior that clearly satisfies all three of these criteria (e.g., Hyde 1976; Taylor and Robbins 1984; Sosa et al. 2011) . In classical new-response acquisition procedures, animals are first given responseindependent pairings of a primary reinforcer and exteroceptive stimulus. Subsequently, the stimulus alone is programmed as the consequence of a novel instrumental response, and the ability of animals to learn to make that response is assessed. In this case, animals do not have the opportunity to associate the instrumental response with the primary reinforcer, as the response that produces the stimulus does not and did not produce the primary reinforcer, and if adequate controls are included, the effects of the specified Pavlovian and instrumental associations can also be established.
New-response acquisition procedures have been used widely to study the conditioned reinforcing effects of food-or water-associated stimuli, and the basic behavioral procedures have been adapted for more complex studies of the associative and neurobiological determinants of performance with conditioned reinforcement (e.g., Beninger and Ranaldi 1994; Beninger and Rolfe 1995; Burke et al. 2007; de Borchgrave et al. 2002; Olausson et al. 2004; Parkinson et al. 1999 Parkinson et al. , 2005 Snycerski et al. 2005) . Despite these advances with non-drug reinforcers, new-response acquisition has not been extensively used to study stimuli paired with drugs of abuse. Early work by Davis, Smith and colleagues (reviewed by Davis and Smith 1987; see also Marcus et al. 1976; Goddard and Leri 2006) showed that rats would increase their responding on a lever that produced a buzzer noise after the noise was paired with response-independent IV injections of morphine or amphetamine, compared to a pre-conditioning baseline period when lever-presses produced the noise and IV saline injection. These results are consistent with the noise becoming a conditioned reinforcer by Pavlovian association with the drug. However, it is difficult to exclude alternative explanations, as these studies did not include a second, inactive lever or other control for nonspecific changes in behavior and/or an associative control to account for potential effects of drug exposure regardless of the programmed drug-stimulus association (see Cunningham 1993 for more on interpreting such pre-vs. post-conditioning designs).
More recently, new-response acquisition procedures have been developed in which self-administration of a drug is trained using one type of manipulandum (e.g., a nose-poke), with each IV drug injection accompanied by a particular stimulus, and then responding on a second type of manipulandum (e.g., a lever) is trained with the stimulus alone. These procedures have been used most commonly to study responding with cocaine-paired stimuli (Di Ciano 2008; Di Ciano and Everitt 2004; Di Ciano et al. 2007 , 2008 Hutcheson et al. 2011; Panlilio et al. 2007; Samaha et al. 2011) or nicotine-paired stimuli (Palmatier et al. 2007 (Palmatier et al. , 2008 . Crucially, among these studies, several studies with both cocaine (Di Ciano and Everitt 2004; Panlilio et al. 2007 ) and nicotine (Palmatier et al. 2007 (Palmatier et al. , 2008 have included both a control manipulandum and an associative control condition to assess the sensitivity of responding to the drug-stimulus pairing. Corresponding studies have not, to our knowledge, been performed with opioid-paired stimuli. In addition to studying cocaine-paired stimuli, Di Ciano and Everitt (2004) did measure rats' acquisition of responding with heroin-paired stimuli; however, no associative control was included for the heroin-paired stimulus in the heroin-trained animals, whereas an unpaired stimulus control condition was included for cocaine-trained animals.
The present experiments characterized rats' acquisition of a novel instrumental response (nose-poking) that produced a light-noise stimulus that had been paired with the potent, short-acting μ-opioid agonist, remifentanil. To establish that acquisition depended on, or was sensitive to, the Pavlovian contingency between the stimulus and remifentanil, animals exposed to stimulus-remifentanil pairings were compared to animals given remifentanil injections and stimulus presentations without consistent pairing (a "truly random" control, Rescorla 1967) . To establish that acquisition depended on the instrumental contingency between a particular response and the stimulus, animals were allowed to choose between an active nose-poke manipulandum, which produced the stimulus, and an inactive nose-poke manipulandum, which had no scheduled consequences. Three experiments were conducted. Experiment 1 characterized rats' responding in two instrumental acquisition (ACQ) sessions after five Pavlovian conditioning sessions. In experiment 2, animals were tested in seven instrumental acquisition sessions after five Pavlovian conditioning sessions. These additional acquisition sessions were conducted to assess the persistence of responding with the stimulus. Experiment 3 assessed the influence of the number of drug-stimulus pairings, giving animals seven acquisition sessions after only one Pavlovian conditioning session. Finally, to investigate the influence of the schedule of reinforcement on new-response acquisition, the active response produced the stimulus under either a random ratio (RR) 2 or fixed ratio (FR) 1 schedule in experiments 2 and 3.
Methods
Subjects Male Sprague-Dawley rats weighing at least 250 g were obtained from Harlan (Indianapolis, IN, USA) to serve as subjects in all experiments. Experimental groups contained eight to 12 rats. Animals were housed individually in a temperature (21-23°C) and humidity controlled facility on a 12-h light/dark cycle (lights on at 7:00 am). Experimental sessions were conducted 6-7 days/week during the light phase of the cycle. All animals had unrestricted access to tap water and standard pellet chow in the home cage for the duration of the experiment. All studies were performed in accordance with the Guide for the Care and Use of Laboratory Animals (Institute of Laboratory Animal Research 1996), as adopted and promulgated by the National Institutes of Health, and all experimental procedures were approved by the University of Michigan Committee on the Use and Care of Animals.
Surgery After at least 7 days of acclimation to the facility, each rat was implanted with a chronic indwelling femoral vein catheter to allow for IV drug administration. Catheterization surgery was performed under ketamine/xylazine (90:10 mg/kg, IP) anesthesia. Catheters, custom made from polyurethane tubing (MRE 040, Braintree Scientific; Braintree, MA, USA) and Tygon tubing (S-54-HL, Norton Performance Plastics; Akron, OH, USA), were inserted into the left femoral vein and routed subcutaneously to the area between the scapulae for externalization. At the scapulae, the catheter was attached to 22-ga stainless steel tubing that was passed through and secured to a Dacron mesh back-plate (DC95BS, Instech Laboratories; Plymouth Meeting, PA, USA). Rats were allowed at least 5 days to recover from surgery before starting experimental sessions. Catheters were flushed with 0.25 ml of saline with heparin (50 U/ml) each day during recovery, as well as before and after experimental sessions to ensure patency.
Apparatus Experimental sessions were conducted in two experimental chambers (ENV-008, Med Associates; St. Albans, VT, USA) contained inside light-and soundattenuating cubicles. Each experimental chamber was located in a separate room of the laboratory. The right wall of each experimental chamber contained a white incandescent houselight (ENV-215M, Med Associates) and a sound generator and speaker (ENV-230 and ENV-224AM, Med Associates). Two nose-poke manipulanda with built-in LED stimulus lights (ENV-114BM, Med Associates) could also be inserted into the right wall. When present, the nose-pokes were located 2.5 cm above the grid floor. The right nosepoke was located 4 cm from the front wall of the experimental chamber, whereas the left nose-poke was located 4 cm from the rear wall. The houselight was centered horizontally between the nose-pokes and located 9 cm above the grid floor. The speaker was located above the right nose-poke, 7.5 cm above the floor. Blank aluminum panels were inserted when the nose-pokes were removed, but all other elements of the experimental chamber remained in place.
IV drug injections were delivered by motorized syringe drivers (PHM-107; Med Associates) through Tygon tubing (S-54-HL, Norton Performance Plastics) connected to a fluid swivel (375/22PS; Instech Laboratories, Plymouth Meeting, PA, USA or QCS-D; Strategic Applications Inc., Lake Villa, IL, USA) and spring tether, which were mounted to a counterbalanced arm. The syringe drivers were located outside of the light-and sound-attenuating cubicles.
Pavlovian conditioning After recovery from catheterization surgery, rats received either "paired" or "random" Pavlovian conditioning (PAV) sessions. During all PAV sessions, the nose-pokes were removed from the experimental chambers, and all animals received response-independent IV injections of remifentanil (3.2 μg/kg delivered in a volume of 100 μl/kg) and response-independent deliveries of a lightnoise compound stimulus. The dose of remifentanil was chosen based on previous work in the laboratory on remifentanil self-administration (Cooper et al. 2008) . The light-noise stimulus consisted of houselight illumination and white noise (80±5 db as measured at the center of the chamber). Injections and stimuli lasted 2.0 ± 0.5 s, depending on the weight of the individual animal. In the paired PAV groups, a single variable time (VT) 3-min schedule controlled both remifentanil injection and stimulus delivery, and injections and stimuli always co-occurred. In the random PAV control groups, remifentanil injection and stimulus delivery were each controlled by independent VT 3-min schedules. Injections and stimuli were not explicitly unpaired. For both paired PAV and random PAV, interinjection/inter-stimulus intervals ranged from 0.0 to 6.0 min. The 3-min average inter-injection interval was chosen based on the half-life of remifentanil (Crespo et al. 2005) to allow for extensive drug metabolism between injections. PAV sessions lasted until 20 injections and 20 stimuli were delivered (approximately 60 min). In experiments 1 and 2, separate groups of animals received paired PAVor random PAV for five consecutive sessions (100 total injections/stimulus deliveries). In experiment 3, all groups of animals received 1 session of paired PAV (20 total injections/stimulus deliveries).
Instrumental acquisition ACQ sessions began the day after the conclusion of PAV. ACQ sessions were conducted the same way following paired PAV and random PAV. During ACQ sessions, the two nose-pokes were present in the experimental chambers. The start of each ACQ session was indicated by the illumination of the stimulus lights inside both nose-pokes, and both nose-pokes remained illuminated for the duration of the session. In each group, the right nose-poke was active for one half of the animals, whereas the left nose-poke was active for the other half of the animals. Responses in the active nose-poke produced the light-nose stimulus alone. No remifentanil injections were given: Animals were attached to the tether, but saline replaced remifentanil on the syringe driver, and the driver did not run at any point. In experiment 1, responses in the active nose-poke produced the stimulus under a modified RR2 schedule. Under the RR2 schedule, the first response in the active nose-poke in each session produced the stimulus with a probability of 1.0, whereas each subsequent response in the session produced the stimulus with a probability of 0.5. In experiments 2 and 3, in separate paired PAV and random PAV groups, responses in the active nose-poke produced the light-noise stimulus under the RR2 schedule or under a FR1 schedule. In all groups, responses in the inactive nose-poke were recorded but had no scheduled consequences. Active and inactive responses made during stimulus presentation were not recorded. All ACQ sessions lasted for 60 min. In experiment 1, ACQ was conducted for two consecutive sessions for all animals. In experiments 2 and 3, ACQ was conducted for seven consecutive sessions for all animals.
Data analysis Based on the acquisition criteria of Cunningham (1993, p. 375 ), two hypotheses were tested: (1) a remifentanil-associated conditioned reinforcer will produce differential responding, i.e., animals will make more active responses than inactive responses after paired PAV, but not after random PAV and (2) a remifentanilassociated conditioned reinforcer will increase responding compared to control animals, i.e., animals will make more active responses after paired PAV than after random PAV. In experiments 1 and 2, for each schedule of reinforcement, the mean number of active and inactive nose-pokes made in each ACQ session was analyzed using a three-way ANOVA with the within-subjects factors of manipulandum (active vs. inactive) and session (ACQ1-2 in experiment 1, ACQ1-7 in experiment 2) and the between-subjects factor of PAV history (paired vs. random). Paired t tests were then used to compare the active and inactive responses of each group in each ACQ session. Following a significant PAV history× manipulandum interaction and nonsignificant interactions involving PAV history and session, responding was averaged across sessions, and unpaired t tests were used to compare the mean active responses of the paired PAV vs. random PAV groups and the mean inactive responses of the paired PAV vs. random PAV groups. The Holm-Bonferroni method was used to correct for multiple pairwise comparisons. In experiment 3, for each schedule of reinforcement, the mean number of active and inactive nose-pokes made in each ACQ session was analyzed using a two-way ANOVA with the within-subjects factors of manipulandum and session. Analyses were performed using Prism 5.0 (GraphPad Software; La Jolla, CA, USA) or SPSS Statistics 20.0 (IBM; Armonk, NY, USA). Differences were considered significant when p<0.05, two-tailed.
Drugs Remifentanil was obtained from the hospital pharmacy of the University of Michigan Health System (Ultiva brand, GlaxoSmithKline; Uxbridge, Middlesex, UK) and dissolved in sterile saline (0.9 %, w/v).
Results
Experiment 1: responding in two ACQ sessions after five PAV sessions Figure 1 presents the nose-poke responses of rats in two ACQ sessions after five sessions of either paired PAV (Fig. 1a) or random PAV (Fig. 1b) . Animals responded differently in the active vs. inactive nose-poke [main effect of manipulandum; F(1, 18) = 6.04, p = 0.024; session × manipulandum: F(1, 18) = 4.45; p = 0.049]. By pairwise comparison, animals that received paired PAV made significantly more active responses than inactive responses in ACQ2 [t(9)=3.55, p=0.012], whereas the active and inactive responses of animals that received random PAV were not different in either ACQ session [0.12<t(9)<1.61, all p's>0.10]. Between groups, however, the effects of PAV history were not significant [main effect and all interactions: 0.24<F(1, 18)<2.82, all p's>0.10].
Experiment 2: responding in seven ACQ sessions after five PAV sessions Figure 2 presents the nose-poke responses of rats in seven ACQ sessions after five sessions of either paired or random PAV. Animals responded under either the RR2 (Fig. 2a-c) or FR1 (Fig. 2d-f) (Fig. 2f) , animals made more active responses after paired PAV than after random PAV [t(18)=3.60, p=0.004], whereas inactive responding did not differ by PAV history [t(18)=0.37, p=0.71] Experiment 3: responding in seven ACQ sessions after one PAV sessions Figure 3 presents the active and inactive responses of rats in seven ACQ sessions after one session of paired PAV. Animals responded under either the RR2 (Fig. 3a) or FR1 (Fig. 3b) schedules of reinforcement. Under the RR2 schedule, responding did not differ by nose-poke [main effect of manipulandum: F(1, 7)=2.07, p=0.19] or across sessions [main effect of session: F(6, 42)=1.74, p=0.13; session× manipulandum: F(6, 42)=1.14, p=0.35]. Under the FR1 schedule, likewise, responding did not differ by nose-poke [main effect of manipulandum: F(1, 9)=3.96, p=0.078] or across sessions [main effect of session: F(6, 54)=0.90, p= 0.49; session×manipulandum: F(6, 54)=0.99, p=0.43]. The trend toward a difference between the nose-pokes under the FR1 schedule is caused by a slight, but persistent, preference for the inactive response over the active response. Because paired PAV did not produce any significant changes in ACQ responding, control groups with one session of random PAV were not tested.
Discussion
Various behavioral processes can change rates of responding when animals are exposed to a drug-paired environmental a b Fig. 3 After one session of PAV, rats do not acquire nose-poke responding with the remifentanil-paired stimulus. a Active and inactive nose-poke responses made by rats (n=8) under the RR2 schedule after one session of paired PAV. b Active and inactive nose-poke responses made by rats (n=10) under the FR1 schedule after one session of paired PAV. All data are presented as the mean±SEM stimulus. These processes may be related to exposure to the drug itself, exposure to the stimulus itself, and/or the drugstimulus pairing. In addition to the conditioned reinforcing effects of the stimulus, responding may be altered by the primary reinforcing effects of the drug, primary reinforcing effects of the stimulus (i.e., sensory reinforcement), discriminative effects of the stimulus, unconditioned effects of drug exposure, nonassociative learning (e.g., habituation to the sensory aspects of the stimulus), and other influences (Cunningham 1993; Kelleher and Gollub 1962; Mackintosh 1974; Williams 1994 ). The present study, therefore, used a behaviorally stringent new-response acquisition procedure to characterize the conditioned reinforcing effects of a lightnoise stimulus that was paired with the μ-opioid agonist, remifentanil.
After five sessions of paired PAV, rats acquired a novel nose-poke response that produced the light-noise stimulus alone. Under both the RR2 and FR1 schedules of reinforcement, significant preferences for the active response developed rapidly (by ACQ2, experiments 1 and 2) and persisted across multiple testing sessions (active > inactive even in ACQ7, experiment 2). Control rats did not acquire nosepoking when the stimulus and remifentanil were not consistently paired. After five sessions of random PAV, no significant preference for the active response was observed in any ACQ session. With the seven ACQ sessions in experiment 2, furthermore, rats made more active responses after paired PAV than after random PAV, and pairing the stimulus with remifentanil selectively affected active responding, as inactive responding did not differ by PAV history under either schedule. Thus, the remifentanil-paired stimulus maintained both differential responding (active > inactive withinsubjects) and increased responding (active > active between subjects). Different criteria may be used to determine when a response has been successfully acquired with either conditioned or primary reinforcement; however, in experimental designs that include two manipulanda, testing for both within-group and between-group differences in active responding may provide a more comprehensive account of the response strength obtained, even if it is not always used as the minimum requirement for a successful demonstration of reinforcement (Cunningham 1993; Snycerski et al. 2005) .
In contrast to the effects of five sessions of paired PAV, rats did not acquire responding under either schedule of reinforcement after one session of paired PAV. These results are consistent with earlier studies of the effects of pairing number on the conditioned reinforcing effects of foodassociated stimuli, as well as more general notions of "associative strength" or the degree of association underlying other behaviors that depend on Pavlovian learning (reviewed by Kelleher and Gollub 1962; Mackintosh 1974) .
Responding with the remifentanil-paired stimulus, therefore, satisfies the three criteria for a sufficient demonstration of conditioned reinforcement (Mackintosh 1974, p. 234) . First, the absence of the nose-poke manipulanda during PAV and the absence of remifentanil during ACQ prevented direct association of the nose-poke response with remifentanil as a primary reinforcer. Rather, the differences between the paired PAV and random PAV groups show that acquisition depended on the Pavlovian pairing of the stimulus with remifentanil. Prior exposure to remifentanil and stimulus presentation without consistent pairing did not produce differential responding during ACQ or as many active responses as paired PAV. Finally, the differences between active and inactive nose-poke responding during ACQ indicate that acquisition was sensitive to the instrumental association between a particular response and the stimulus as a consequence of that response. The side of the active nose-poke (left vs. right) was counterbalanced across animals in each group, and the houselight and speaker were not consistently located above the active nose-poke. It is, therefore, unlikely that either a spatial bias or Pavlovian-conditioned approach was the sole basis for differential responding. Likewise, both nose-pokes simply remained illuminated for the duration of the session, and so the differences in responding are unlikely to have emerged from a difference in the sensory aspects of the active vs. inactive manipulanda themselves. This is not to say that independently programmed or randomized presentations of drugs and environmental stimuli have no effect on behavior, or that the random control groups learned nothing during their PAV sessions. Even with the significant differences between the paired PAV and random PAV groups reviewed above, it is noteworthy that the animals in the random PAV groups responded throughout ACQ, making ∼5-10 active and inactive responses per session. This responding may be due to associative processes (e.g., from pairing the experimental chamber generally with remifentanil) and/or nonassociative processes (e.g., reactions to the nose-poke manipulanda as novel objects). Some of these same processes may have also influenced the responding of the paired PAV groups, in addition to the effects of the remifentanil-stimulus pairing. Presently, a random control procedure was chosen to ensure that the experimental and control groups were matched for their exposure to the individual experimental elementstotal remifentanil exposure and total exposure to the lightnoise stimulus-during PAV (Cunningham 1993) . However, there continues to be debate about the procedures that comprise adequate controls for Pavlovian conditioning (e.g., Kirkpatrick and Church 2004; Miller and Matzel 1989; Papini and Bitterman 1990) . The present study cannot address the presence or absence of learning in the random PAV groups, except to note that whatever learning occurred did not produce the same effect on nose-poke responding that paired PAV did, and so the differences between the groups in this target behavior are still relevant to understanding how a specific drug-paired stimulus can influence a specific behavior.
In human drug abuse and dependence generally, Pavlovian drug-associated stimuli are thought to play a number of distinct, but interacting, roles in maintaining drug self-administration behaviors and provoking relapse (reviewed by Milton and Everitt 2010) . As conditioned reinforcers, specifically, drug-paired stimuli may help to sustain (1) prolonged sequences or chains of behavior that ultimately lead to drug consumption and (2) drug-seeking responses in extinction, when the drug itself is unavailable (Milton and Everitt 2010) . Human drug abusers are often required to engage in long, complex sequences of behavior to obtain and prepare drugs prior to consuming them, and laboratory animals can also be trained to produce extended multioperant chains with self-administered drug (e.g., Thompson and Pickens 1969, Fig. 9 ). Reducing the conditioned reinforcing of drug-paired stimuli may disrupt the performance of such chains, reducing access to and drugtaking in their terminal links. Next, by maintaining existing responses and training new responses in the absence of the drug itself, conditioned reinforcers may both complicate the detoxification process, as individuals attempt to break ongoing patterns of drug self-administration, and contribute to relapse after extended abstinence. The persistent preference for the active response observed in the present study is noteworthy in this regard. Historically, researchers have questioned whether new-response acquisition behavior is too transient to be of practical use in studying conditioned reinforcement: Because responses during instrumental acquisition necessarily present the stimulus in the absence of the primary reinforcer, Pavlovian extinction may rapidly reduce or eliminate the conditioned reinforcing effects of the stimulus (Mackintosh 1974; Williams 1994) . Many of the detailed interactions of Pavlovian and instrumental learning remain to be clarified (e.g., Palmatier et al. 2008 ), but it is becoming increasingly clear that sustained responseacquisition performance can be obtained with drug-paired stimuli (see also Di Ciano and Everitt 2004; Di Ciano et al. 2008) . Altogether, therefore, interventions that reduce the conditioned reinforcing effects of drug-paired stimuli may help to make drug-taking and drug-seeking behaviors less diverse and less sustainable. It is important to note that, to date, such cue exposure therapies have not produced consistent clinical benefits, but they may be refined as new research into animal learning is translated into work with human drug users (e.g., Conklin and Tiffany 2002; Xue et al. 2012) . New-response acquisition procedures may provide useful models for studying the enduring control that drug-paired stimuli can exert over behavior because of their conditioned reinforcing effects, specifically, and for testing interventions designed to alter that control.
